Acp-204-006
ClinicalTrials.gov NCT06159673
Research payments
$6,839,060
Through program year 2025, $6,839,060 in research payments was reported against Acp-204-006, across 1,580 payments, paid by ACADIA Pharmaceuticals Inc.
- Paid by
- ACADIA Pharmaceuticals Inc
- ClinicalTrials.gov
- NCT06159673
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $4,632,399 | 1,098 |
| 2024 | Research | $2,206,661 | 482 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
8 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Yaneicy Gonzalez Rojas Coral Gables, FL Named on 298 payments
- Angel Carrasco Miami, FL Named on 265 payments
- Kenia Castro Hialeah, FL Named on 240 payments
- Pilar Trueba Doral, FL Named on 185 payments
- Aniel Navarro Marin Miami, FL Named on 96 payments
- Emelina Arocha Miami, FL Named on 59 payments
- Jorge Betancourt Mia, FL Named on 43 payments
- Emilio Mantero-Atienza Miami Beach, FL Named on 37 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.